RT Journal Article SR Electronic T1 Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology JF Lupus Science & Medicine JO Lupus Sci Med FD Lupus Foundation of America SP e000840 DO 10.1136/lupus-2022-000840 VO 9 IS 1 A1 Bessie Stamm A1 Medha Barbhaiya A1 Caroline Siegel A1 Sarah Lieber A1 Michael Lockshin A1 Lisa Sammaritano YR 2022 UL http://lupus.bmj.com/content/9/1/e000840.abstract AB Fertility is often a concern for women with SLE. In addition to known indirect factors that influence the ability of a woman with SLE to become pregnant, such as cytotoxic agents, other medications, advanced age and psychosocial effects of the disease, direct disease-related factors are believed to influence fertility. These include diminished ovarian reserve, menstrual irregularities (a function of disease activity) and the presence of antiphospholipid antibodies. The question of whether SLE intrinsically affects fertility, however, remains unanswered. In this review, we address known factors affecting fertility, assess current data regarding a direct impact of SLE on fertility and evaluate potential disease-related risk factors. We focus primarily on studies measuring anti-Müllerian hormone and antral follicle count, the most widely measured markers of ovarian reserve. Our goal is to provide information to rheumatologists faced with counselling patients with SLE regarding their fertility, family planning and options for assisted reproductive technologies, which now include fertility preservation through oocyte cryopreservation.